Non-invasive NESA Neuromodulation Versus Transcutaneous Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder

What this Trial Is About

Overactive bladder (OAB) is a common condition causing urgency, frequent urination, and sometimes urge incontinence. Researchers are evaluating non-invasive neuromodulation techniques as alternative treatments for OAB patients who have not responded well to conventional therapies. This study aims to compare the effects of non-invasive NESA neuromodulation with posterior tibial nerve stimulation on quality of life, symptoms, discomfort, and sleep in adults with OAB. The study involves 24 women aged 38 to 85 years who will undergo ten treatment sessions twice a week. One group will receive NESA neuromodulation using a device that emits very low frequency, intensity, and voltage currents through electrodes on gloves and anklets, combined with pelvic exercises and patient education. The other group will receive transcutaneous posterior tibial nerve stimulation using a TENS device with electrodes placed along the tibial nerve pathway, also combined with pelvic exercises and education. Participants will be assessed before treatment, immediately after the ten sessions, and at two months post-treatment. Researchers will measure quality of life with the SF-36 questionnaire, sleep quality with the Pittsburgh questionnaire, urinary incontinence symptoms with the ICIQ-SF, bladder control with the B-SAQ, and patient satisfaction at follow-up. The study includes monitoring for safety and adherence, with all participants providing informed consent.

NESA Neuromodulation Versus Transcutaneous Posterior Tibial Stimulation